Author

R. Mertes

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Lehmann· 1 shared E. Corrales· 1 shared E. Levit-Zerdoun· 1 shared J. Muench· 1 shared M. Boerries· 1 shared P. Metzger· 1 shared S. Kowar· 1 shared S. Lemke· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Lehmann

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma

E. Corrales, E. Levit-Zerdoun, P. Metzger, R. Mertes, A. Lehmann, J. Muench, S. Lemke, S. Kowar, M. Boerries

This study identifies PI3K/AKT pathway activation as a mechanism for MAPK/ERK pathway independency in melanoma, leading to treatment resistance and stem-like properties.

bioRxiv · Jul 8, 2022Cancer Biology